REMONY

Search documents
Japan Ground Self-Defense Force Adopts MEDIROM MOTHER Labs’ REMONY for Advanced Health Monitoring and Heatstroke Safety
Globenewswire· 2025-09-18 21:00
Core Viewpoint - MEDIROM Healthcare Technologies Inc. has announced the deployment of its remote health monitoring system "REMONY," utilizing the recharge-free smart tracker MOTHER Bracelet, to the Japan Ground Self-Defense Force (JGSDF) [2] Background of the Deployment - The need for effective health management and heatstroke prevention for personnel in extreme conditions has increased significantly [3] - Traditional wearable devices have limitations in remote areas with scarce power supply, making continuous health data collection challenging [4] Technology and Features - The MOTHER Bracelet employs thermoelectric generation technology, allowing uninterrupted operation without battery concerns, which was crucial for its adoption [5] - The device enables real-time health monitoring, helping to proactively identify risks such as heatstroke during extended missions [5] - The MOTHER Bracelet is the world's first 24/7 recharge-free smart tracker, utilizing temperature differences for power generation, thus preventing data loss during recharging [8] - It records five key metrics: heart rate, calories burned, body surface temperature, step count, and sleep [8] REMONY System Overview - REMONY combines the MOTHER Bracelet with a dedicated gateway for automatic data synchronization and centralized real-time management [11] - The system allows for continuous health monitoring without the need to remove the device for recharging, facilitating prompt detection of health emergencies [11] - It is customizable for various industries, including elderly care and health monitoring for night shift workers [11] Company Background - MEDIROM MOTHER Labs Inc., a subsidiary of MEDIROM Healthcare Technologies, focuses on health-tech solutions, including the development and sales of the MOTHER Bracelet [14]
Medirom’s “REMONY” Certified by MLIT as a Fatigue-Driving Prevention Device
Globenewswire· 2025-08-28 21:00
Core Viewpoint - MEDIROM Healthcare Technologies Inc. has announced that its "REMONY for Driver" remote health management system has been certified by Japan's Ministry of Land, Infrastructure, Transport and Tourism as a device for preventing fatigue-related driving [2][4]. Group 1: Product Overview - "REMONY for Driver" utilizes the MOTHER Bracelet, a 24/7 wearable device that monitors drivers' health and alertness, featuring a proprietary sleep assessment function [3][11]. - The MOTHER Bracelet is the world's first recharge-free smart tracker, generating power from temperature differences, thus eliminating data loss during recharging [11][14]. - The system allows for real-time health monitoring and trend analysis, which can help prevent health-related accidents [3][14]. Group 2: Subsidy Program - The "REMONY for Driver" system is eligible for a subsidy covering 50% of the equipment acquisition cost, with a general cap of 800,000 yen per business operator [4][5]. - The Ministry of Land, Infrastructure, Transport and Tourism allocated approximately 1.3 billion yen in subsidies in the previous fiscal year, with a similar budget expected for the current fiscal year [4]. Group 3: Future Outlook - The company aims to enhance system functionality and promote safe driving practices, focusing on preventing fatigue-related driving in the transportation industry [8]. - Future initiatives include conducting safety check-in operations based on health data and improving driver health and workplace environments [7][8].
MEDIROM Healthcare Technologies Inc. Regains Compliance with NASDAQ Continued Listing Requirements
Globenewswire· 2025-06-05 18:02
Core Points - MEDIROM Healthcare Technologies Inc. has regained compliance with Nasdaq's minimum bid price requirement as of June 4, 2025 [1][3] - The company was previously notified on February 27, 2025, that it was not in compliance, needing to maintain a minimum closing bid price of $1.00 per share for at least 10 consecutive business days [2] - The closing bid price of the company's American Depositary Shares (ADSs) was $1.00 or greater for the required period from May 20, 2025, to June 3, 2025 [3] Company Overview - MEDIROM operates over 300 wellness salons in Japan, with its leading brand being Re.Ra.Ku® [4] - The company entered the health tech business in 2015 and launched an on-demand training app called "Lav®" [4] - In 2020, MEDIROM developed a smart tracker, the "MOTHER Bracelet®," and in 2023, it launched REMONY, a remote monitoring system for corporate clients across various industries [4] - MEDIROM aims to leverage its diverse portfolio to collect and manage healthcare data, positioning itself as a leader in healthcare big data in Japan [4]
Specific Health Guidance Service Utilizing the "Lav" Healthcare App: Surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals!
GlobeNewswire News Room· 2025-05-30 13:00
Core Insights - MEDIROM Healthcare Technologies Inc. has announced that its subsidiary, MEDIROM MOTHER Labs, has surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals using its health guidance service via the "Lav" app [2][5] - The "Lav" app, launched in 2019, provides continuous health support through information and communication technology, receiving high evaluations from health insurance associations and company employees [2][11] - The total weight loss achieved by all "Lav" users since the app's implementation has reached 15,421 kilograms, equivalent to approximately 2.2 African elephants or 10 cars [7] Company Overview - MEDIROM operates over 300 wellness salons across Japan, with its leading brand being Re.Ra.Ku, and has expanded into health tech since 2015 with the launch of the "Lav" app [17] - The company also entered the device business in 2020 with the development of the "MOTHER Bracelet" and launched a remote monitoring system called REMONY in 2023, catering to various industries [17] - MEDIROM aims to leverage its diverse health-related products and services to collect and manage healthcare data, positioning itself as a leader in big data within the healthcare industry [17] Specific Health Guidance Program - The Specific Health Guidance Program, implemented by Japan's Ministry of Health, Labor and Welfare, targets medical insurance subscribers aged 40-74 to prevent lifestyle-related diseases [10] - The program includes specific health checkups and guidance from public health nurses and registered dietitians, focusing on improving diet and exercise habits for those at risk of metabolic syndrome [10] - The "Lav" app enhances this program by allowing users to track their health status and receive personalized advice from professional coaches, making health promotion more accessible [11]
MEDIROM Healthcare Technologies Inc. Announces 22% Rise in Revenue and 20% Improvement in Earnings for 2024; Webcast to Discuss Financial Results to be held on May 21st, 2025 at 8:30 AM ET
Globenewswire· 2025-05-20 12:56
Core Insights - MEDIROM Healthcare Technologies Inc. reported total revenue of $52,736,000 for the year ended December 31, 2024, representing a 22% increase from $43,388,000 in 2023 [1] - The net income for 2024 was $878,000, or $0.17 per basic share, a 20% improvement compared to $731,000, or $0.15 per basic share, in 2023 [1] Revenue Growth - The revenue growth in 2024 was primarily driven by a 23% increase in the Relaxation Salon Segment revenue, which reached $47,317,000 compared to $38,507,000 in 2023 [2] Cost Management - The increase in net income was attributed to a rise in total revenue, a decrease in the cost of revenues as a percentage of total revenues to 72.9% in 2024 from 77.0% in 2023, and a reduction in selling, general, and administrative expenses as a percentage of total revenues to 27.0% in 2024 from 28.7% in 2023 [3] Financial Position - As of December 31, 2024, MEDIROM had cash and cash equivalents of $2,093,000, up from $676,000 as of December 31, 2023 [4] - The total indebtedness increased to $11,925,000 in 2024 from $9,857,000 in 2023 [4] Cash Flow Analysis - Net cash used in operating activities was $8,462,000 in 2024, compared to $4,014,000 in 2023 [5] - Net cash provided in investing activities was $2,296,000 in 2024, while there was net cash used of $2,088,000 in 2023 [5] - Net cash provided by financing activities was $7,583,000 in 2024, an increase from $2,931,000 in 2023 [5] Strategic Developments - In 2025, MEDIROM announced the launch of its remote health monitoring system, REMONY, and the MOTHER Bracelet, targeting corporate clients [6] - The company aims to capture a significant share of the Japanese relaxation salon market and expand its Digital Preventative Healthcare business lines [6]